[20190517]IF11214_药品定价与法律:药品专利纠纷.pdf

上传人:任我行 文档编号:28209 上传时间:2022-06-24 发布时间:2019-05-17 格式:PDF 页数:3 大小:421.88KB
下载 相关 举报
[20190517]IF11214_药品定价与法律:药品专利纠纷.pdf_第1页
第1页 / 共3页
[20190517]IF11214_药品定价与法律:药品专利纠纷.pdf_第2页
第2页 / 共3页
[20190517]IF11214_药品定价与法律:药品专利纠纷.pdf_第3页
第3页 / 共3页
亲,该文档总共3页,全部预览完了,如果喜欢就下载吧!
资源描述

1、 https:/crsreports.congress.gov May 17, 2019Drug Pricing and the Law: Pharmaceutical Patent DisputesPatent rights play an important role in the development and pricing of pharmaceutical products. Patent law seeks to encourage innovation by granting the holder of a valid patent a temporary monopoly o

2、n an invention, potentially enabling him to charge higher-than-competitive prices. Patent disputes relating to the entry of follow-on pharmaceuticals are subject to specialized procedures. Because patent rights may deter or delay competition from generic drug and biosimilar manufacturers, these proc

3、edures can affect whether and when follow-on products can enter the market, influencing the prices of patented pharmaceuticals. This In Focus provides an overview of the complex procedures governing pharmaceutical patent disputes. FDA Regulation of Drugs and Biologics Drugs and biological products (

4、biologics) are both articles used in the diagnosis, cure, mitigation, treatment, or prevention of human disease. Nonbiological drugs do not derive from living organisms, and are generally artificially synthesized, small-molecule chemicals. In contrast, biologics are generally large, complex molecule

展开阅读全文
相关资源
猜你喜欢
相关搜索
资源标签

当前位置:首页 > 法规条令 > CRS 美国国会研究处报告